Interim results of phase 2A study of VX-770 to evaluate safety, pharmacokinetics, and biomarkers of CFTR activity in CF subjects with G551D
Product/Publication Type(s):
Peer-reviewed publications in scholarly journals Published/In Press
To Obtain Copies (URL or Email):
COVID-19 Related Data:
N/A